Medicus Pharma Ltd.
MDCXW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001997296
No open-market purchases or sales by Medicus Pharma Ltd. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $63.6K in total; no superinvestor holds it.
Other share classesMDCX
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −2 vs. previous quarter
- 4
- 13F valueReported value at the end of Q2 2026
- $63.6K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding MDCXW, Q2 2026
No superinvestor reported holding MDCXW at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Medicus Pharma Ltd. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 21, 2025 (view filing)12:57 PM ET | May 20 | 1 day | Velocity Fund Partners, LP and 1 other10% Owner | SSaleMedicus Pharma LTD | −75.0K | $7.72 | −$578.9K | −2.3%3.25M after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Medicus Pharma Ltd. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 60,600 | $39.4K | 0.00% | 00.0% | Unchanged |
| Anson Funds Management LP | 42,400 | $18.9K | 0.00% | −42,400−50.0% | Reduced |
| Connective Capital Management, LLC | 6,000 | $3.90K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,203 | $1.43K | 0.00% | +738+50.4% | Added |